Bristol-Myers Squibb Company, founded in 1858, is a global biopharmaceutical company renowned for its innovative medicines.
The company has a rich history of pioneering breakthrough treatments across various therapeutic areas such as oncology, cardiovascular, immunoscience, and fibrosis.
Bristol-Myers Squibb’s business operations encompass research, development, manufacturing, and marketing of pharmaceuticals worldwide.
Significant acquisitions and mergers have expanded its portfolio significantly, including the acquisition of Celgene Corporation in 2019, a landmark deal valued at $74 billion. This strategic move strengthened its presence in the oncology and immunology field.
In its overall movement, the Bristol-Myers Squibb Company’s share has experienced much volatility, showing only moderate growth.
For instance, anyone who invested in the company in the downs of October 2016, observing the bearish run and thinking it to be the right opportunity to enter, would have generated almost 0% returns until February 2024.
However, in 2019, the stock price rose significantly (nearly 90% till June 2022) due to the successful launch of several new cancer drugs, including Opdivo and Revolade.
This endorses the fact that the pharmaceutical sector is highly dependent on research and development (R&D) success. Positive clinical trials and successful drug launches can significantly impact share prices.
Bristol-Myers Squibb Share Price History
| Year | Share Price | Gain / Loss |
|---|---|---|
| 1994 | $ 14.47 | |
| 1995 | $ 21.47 | + 48.4% |
| 1996 | $ 27.25 | + 26.9% |
| 1997 | $ 47.31 | + 73.6% |
| 1998 | $ 66.91 | + 41.4% |
| 1999 | $ 64.19 | - 4.1% |
| 2000 | $ 73.94 | + 15.2% |
| 2001 | $ 51.00 | - 31.0% |
| 2002 | $ 23.15 | - 54.6% |
| 2003 | $ 28.60 | + 23.5% |
| 2004 | $ 25.62 | - 10.4% |
| 2005 | $ 22.98 | - 10.3% |
| 2006 | $ 26.32 | + 14.5% |
| 2007 | $ 26.52 | + 0.8% |
| 2008 | $ 23.52 | - 11.3% |
| 2009 | $ 25.25 | + 7.4% |
| 2010 | $ 26.48 | + 4.9% |
| 2011 | $ 35.24 | + 33.1% |
| 2012 | $ 32.59 | - 7.5% |
| 2013 | $ 53.15 | + 63.1% |
| 2014 | $ 59.03 | + 11.1% |
| 2015 | $ 68.79 | + 16.5% |
| 2016 | $ 58.44 | - 15.0% |
| 2017 | $ 61.28 | + 4.9% |
| 2018 | $ 51.98 | - 15.2% |
| 2019 | $ 64.19 | + 23.5% |
| 2020 | $ 62.03 | - 3.4% |
| 2021 | $ 62.35 | + 0.5% |
| 2022 | $ 71.95 | + 15.4% |
| 2023 | $ 51.31 | - 28.7% |
| 2024 | $ 52.90 | + 3.1% |
Bristol-Myers Squibb Share Price Chart
Click here for high resolution Bristol-Myers Squibb Share Price chart
Bristol-Myers Squibb Share Returns Calculator
Enter any amount in the 'Investment amount' field and select a year.
The Bristol-Myers Squibb calculator will tell you the value of your Bristol-Myers Squibb investment in 2024.
Invested Amount
Investment Year
- During 1994, the share price of Bristol-Myers Squibb was $ 14.47.
- If you had bought shares worth $ 2500 in 1994, you would have 1728 shares today.
- At the end of 2024, the current value of your shares would be $ 91396.
Bristol-Myers Squibb Share Returns Comparison
Invested Amount
Investment Year
Other Investment
Interest Rate